DCVC Opportunity Fund II GP, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001668343
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2024 · 3 positions · Total reported value $97.38M · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 0.0% · 0 new · 0 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q3 2024 13F filing, DCVC Opportunity Fund II GP, LLC disclosed 3 equity positions with a combined reported value of $97.38M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Industrials Tilt / Buy & Hold.
The largest disclosed positions as of Q3 2024 were RKLB ($70.09M), RXRX ($26.04M), RGTI ($1.25M). By sector, the heaviest allocations are Industrials 72.0%, Health Care 26.7%. Versus the prior quarter, allocation shifted toward Industrials (+19.5pp) and away from Technology (-1.3pp), Health Care (-18.2pp).
Versus the prior quarter, DCVC Opportunity Fund II GP, LLC opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Insider Transactions (Form 4)
Latest DCVC Opportunity Fund II GP, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
DCVC Opportunity Fund II GP, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 2 positions worth $18.54M in total. HoldingsHub carries 12 quarters of its filings (Q4 2023–Q3 2026).
Portfolio Structure
- 2 positions · $18.54M reported value (Q3 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: RXRX (RECURSION PHARMACEUTICALS IN) at 88.0%
- Average position size: $9.27M
Sector Tilt
- Health Care 88.0%
- Information Technology 12.0%
- (classified holdings cover 100% of value)
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
FAQ
What did DCVC Opportunity Fund II GP, LLC buy in 2024-Q3?
In its 2024-Q3 13F filing, DCVC Opportunity Fund II GP, LLC reported 3 equity positions worth $97.38M in aggregate; its largest disclosed positions were RKLB ($70.09M), RXRX ($26.04M), RGTI ($1.25M).
How large is DCVC Opportunity Fund II GP, LLC's portfolio?
DCVC Opportunity Fund II GP, LLC reported $97.38M of long equity holdings across 3 positions as of 2024-Q3. Top-10 holdings account for 100.0% of reported value.
What is DCVC Opportunity Fund II GP, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Industrials Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.